Early Detection
The oral cavity is an easily accessible part of the body, and examinations for oral cancers can increase the likelihood of detecting these life-threatening cancers. However, most oral cancers are not detected at an early stage, when treatment is most effective. Although dentists are most likely to perform an oral cancer examination, all primary health care providers, including physicians, nurses, and dental hygienists, should perform regular oral cancer examinations for patients who have been identified at high risk for oral cancer (4, 5) .
SIGNS AND SYMPTOMS OF ORAL CANCER
• A mouth sore that fails to heal or that bleeds easily.
• A white or red patch in the mouth that will not go away.
• A lump, thickening, or soreness in the mouth, throat, or tongue.
• Difficulty chewing or swallowing food.
Prevention
Primary prevention strategies may offer the best opportunity for reducing oral cancer deaths and disease. Health care providers should counsel patients about the use of tobacco and alcohol, high risk behaviors that increase the likelihood of developing oral cancer (4, 5) . The use of tobacco is a contributing factor in at least 75% of all oral cancers (4, 6, 7) . Cigarettes have been established as a direct cause of oral cancer. There is strong evidence that snuff can cause oral cancer, and chewing tobacco increases the risk of tissue changes in the mouth that can lead to oral cancer. Among cigar and pipe smokers, oral cancer mortality rates are similar to or higher than among cigarette smokers. Avoidance of risk behaviors such as smoking, spit tobacco use, and excessive alcohol drinking are critical in preventing oral cancers.
The deadly combination of heavy drinking and heavy smoking greatly increases the risk of developing oral cancer.
All forms of alcohol in excess (including beer, wine and liquor) can increase the risk of developing oral cancer (4,7). 41,081 adults at high risk for oral cancer because of cigarette and alcohol use had no dental or medical visit in the past year.
Risk Behaviors
In 1996, 379 cases of oral cancer were reported to the Oregon Cancer Registry. More than twice as many males (259) were reported to the registry as females (120).
Tobacco
Among the adult population, 21.9% smoke cigarettes, compared to 22% nationwide in 1995. Of those adults currently smoking 15.9 % smoke 25 or more cigarettes each day. Adults ages 25-34 have the h i g h e s t s m o k i n g r a t e s i n Oregon whereas as a slightly older group, 35-44 year-olds have the highest median rate of smoking for the United States.
In 1995, 3.6% of the adult male population reported the use of smokeless tobacco.
Alcohol
About 14.4% of adults in Oregon engaged in risky drinking behaviorsconsuming more than 60 drinks per month or consuming more than five drinks on at least one occasion during the month. Younger adults were more likely to report risky drinking behaviors than older adults.
In Oregon, about 5.7% of adults are at increased risk of oral cancer because of combined alcohol and tobacco use, compared to 5% nationwide. who treat older populations the need to provide screening for oral cancers, as 76 % of those 65 and older who havent seen their dentist have seen their doctor within the last 12 months. Although 56% of the general population has dental insurance, only 25 percent of seniors have dental insurance coverage.
Health Care Utilization

Prevention
In August 1996, the Centers for Disease Control and Prevention, in collaboration with other organizations, held a Conference concerning prevention of Oral and Pharyngeal Cancer. They recommended more public education so people would know that an examination for oral cancer exists and that they can and should request one routinely from a variety of health care providers. The public also needs to know the signs and symptoms of oral cancer, the risk factors for the disease, and ways to reduce risk. This is particularly important for high-risk groups of tobacco and alcohol users.
The recommended strategies for patient education include:
counseling patients that snuff and chewing tobacco are not safe substitutions for smoking cigarettes.
avoidance of risk behaviors such as smoking, spit tobacco use, and excessive alcohol drinking are critical in preventing oral cancers. (9) ALZHEIMERS PARKINSONSDISEASE This article focuses on two debilitating diseases that are affecting a growing number of Oregonians: Alzheimer's disease and Parkinson's disease. Both are the subject of intense research efforts, but as of now too often prove fatal. As our population ages, an increasing number of people will be at risk from these disorders. This article provides a brief overview of what is known about Alzheimer's and Parkinson's disease, including historical mortality trends, risk factors, and the demographic characteristics of the decedents.
Alzheimer s Disease
Year Oregon has the third highest Alzheimers disease death rate in the nation. Although the death rate for this disease has risen markedly nationwide since 1979, the magnitude of the increase has been larger in Oregon (Figure 1 ).
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The following briefly describes the nature of Alzheimers disease 3 and the demographic characteristics of people dying from the disease.
WHAT IS ALZHEIMER'S DISEASE?
Alzheimers disease was first described in 1906 by the German neurologist Alois Alzheimer. The disease is characterized by the Oregon's Alzheimer's disease age-adjusted death rate is 56%
higher than the nation's.
Oregon's Alzheimer's disease age-adjusted death rate is almost four times higher than that of New York's, the state with the lowest rate, 6.4 vs. 1.7.
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destruction of brain cells resulting in a decline in mental functions that affects memory, language, motor skills, abstract thinking, sensory function, ability to recognize objects, and behavior. Anatomical changes include diffuse atrophy throughout the cerebral cortex with attendant, highly distinctive pathological changes including plaques and neurofibrillary tangles. The plaques are microscopic lesions made up of fragmented axon terminals and dendrites enveloping a core of beta-amyloid protein. Neurofibrillary tangles are intracellular clumps or knots of neurofibrils within individual diseased neurons.
The principal cognitive feature of the disease is usually progressive memory impairment. In the early stages of the disease, the person may forget small things, like a doctors appointment or peoples names. As the disease progresses, recall of remote well-learned material may appear to be preserved, but new information cannot be adequately incorporated into memory. Later stages are marked by disorientation and confusion; personality changes are commonly reported and range from progressive passivity to marked agitation. In some cases, personality changes may predate cognitive abnormality. Depressive symptoms are present in up to 40 percent of the victims, and psychosis occurs in 25 percent. Ultimately, as brain function decreases, the ability to talk, move, and to provide selfcare is eventually lost.
WHO DOES ALZHEIMER'S DISEASE AFFECT?
Although the disease can occur in people in their 30s, more often it affects those 65 and older. The prevalence increases dramatically with age, from about 3 percent of people ages 65-74 to 19 percent of those 75-84 to 47 percent of those 85 or older. At least four million Americans are The risk is greatest among elderly females.
estimated to have Alzheimers, and with increasing life spans and population, the number is expected to increase to nearly 15 million over the next fifty years. Already, the financial burden arising from the disease is about $100 billion annually in the U.S.; this includes the cost of care and lost productivity. But beyond the economic costs, the human toll of Alzheimers immense, from the victims to caregivers to society as a whole.
WHAT CAUSES ALZHEIMER'S DISEASE?
The underlying cause(s) of this disorder remains unclear this time. However, a number of risk factors have been identified including: age, female gender, genetic predisposition, certain circulatory disorders, head injuries, deficiencies of antioxidant nutrients, family history of Down syndrome, and environmental factors. Other factors have been found to be associated with a lower risk of Alzheimers disease, for example, more frequent use of nonsteroidal anti-inflammatory drugs and estrogen replacement therapy (among postmenopausal women). However, the possible role of these factors in the development of the disease is currently uncertain.
WHAT DO THE OREGON DATA SHOW?
An Increasing Number of Deaths. Since 1993, more than 500 Oregonians have died annually from Alzheimers disease. Part of this increase is attributable to the aging of the population, but even after controlling for this trend by calculating ageadjusted death rates, the rates have risen inexorably for many years. 4 Since 1979, the states crude death rate has increased 43-fold while the age-adjusted death rate increased 16-fold. 
OR LESS
Note: Some rates are based on a small number of events.
Rates are per 100,000 population. The degree to which the increase in Alzheimers mortality is partially an artifact of improved reporting is uncertain, but as diagnostic procedures have evolved, so too has the likelihood that more accurate diagnoses have contributed to the apparent increase in Alzheimerscaused deaths. Even so, physicians have continued to attribute deaths to senility and other senile dementias; the age-adjusted death rate for these causes rose more than threefold during 1979-95.
Sex. Oregon females were twice as likely to die of Alzheimers disease than were males; their death rate was 30.8 per 100,000 population compared to 15.5 for males. The overall rate was 23.3.
Age. Alzheimers deaths rarely occur before age 55. However, by age 65, the death rate begins to rise sharply with advancing age. Oregonians 80 or older were more than 20 times as likely to die of the disease than were 65-to 74-year-olds (Figure 2) .
County of Residence. Of the 12 counties with the highest Alzheimers disease age-adjusted death rates during 1986-95, eight were west of the Cascade Range.
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Great Basin and adjacent counties were notable for their low death rates.
Oregonians Dying from
Alzheimer's Disease 1979: 15 1996: 743 Figure 3 shows the counties sorted into three equal groups by rate. The highest death rate was recorded for Josephine County; it was 78 percent above the states rate (Table 1) . Alzheimers disease death rates were at least one-third higher than the states rate in three other counties as well: Hood River (51% higher), Tillamook (43%), and Klamath (39%).
WHAT TREATMENT IS AVAILABLE?
Until recently, nothing seemed to slow the inexorable decline caused by Alzheimers disease. However, during the 1990s two drugs have been licensed by the FDA for treatment of the disorder: Aricept and Cognex. These medications do not stop or reverse the progression of Alzheimers disease, but they do slow the decline in cognitive functioning. Many other treatments are in development. Parkinson's Disease
Oregon has the highest Parkinsons disease death rate in the nation. Although the death rate for this disease has risen markedly nationwide since 1979, the magnitude of the increase has been larger in Oregon (Figure 1) . The following briefly describes the nature of the disease 1 and the demographic characteristics of people dying from Parkinsons disease.
WHAT IS PARKINSON'S DISEASE?
First described by James Parkinson in 1817, Parkinsons disease is a chronic progressive disease of the nervous system characterized by the deterioration of neurons (a type of cell found in the brain). Neurons produce dopamine, a chemical messenger that helps the nervous system control muscle activity. When these neurons are destroyed, dopamine is not produced at the normal rate, and the resulting abnormally low supply of dopamine causes Parkinsons symptoms to appear. These include: stiffness, tremor, fixity of expression, slowness and poverty of movement, a shuffling gait, difficulty with balance, and difficulty walking. Secondary symptoms of Parkinsons disease may include: depression, senility, postural deformity, and difficulty in speaking. Typically, the disease progresses very slowly.
WHO DOES PARKINSON'S DISEASE AFFECT?
Most commonly diagnosed are people over the age of 60, but about 10 percent are diagnosed before age 50. Nationally, 1.5 million Americans are thought to have the illness, with another 50,000 people being diagnosed annually. Oregon's Parkinson's disease age-adjusted death rate is 63% higher than the nation's.
Year
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WHAT CAUSES PARKINSON'S DISEASE?
The underlying cause of this disorder remains unclear this time. There may be multiple causes that share a final common pathway resulting in Parkinsonian symptoms. Some known causes include certain designer drugs (e.g., MTMP), and an outbreak of a flu-like infection during the first two decades of this century. Areas under investigation include: the environment, toxins, infectious disease, accelerated aging, and genetic predisposition.
WHAT DO THE OREGON DATA SHOW?
An Increasing Number of Deaths. Since 1995, more than 200 Oregonians have died annually from Parkinsons disease. Part of this increase is attributable to the aging of the population, but even after controlling for this trend by calculating ageadjusted death rates, the death rates have risen inexorably for many years.
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Since 1979, the states crude death rate has increased 243 percent while the ageadjusted death rate increased 160 percent.
3 By comparison, rates for the United States have increased 156 percent and 78 percent, respectively.
Sex. Oregon males are 71 percent more likely to die from Parkinsons disease than are females; their death rate was 9.4 per 100,000 population, compared to 5.5 for females (Table  1) .
Age. Parkinsonism deaths rarely occur before age 55. However, by age 65, the death rate rises sharply, particularly among males.
County of Residence. Although Parkinsons disease age-adjusted death rates during 1986-95, were more often lower for counties east of the Cascade Range 
